VCIM
IMNM icon

Velan Capital Investment Management’s Immunome IMNM Stock Holding History

Velan Capital Investment Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$219K Hold
10,000
– – 0.14% 37
2025
Q4 		$215K Hold
10,000
– – 0.12% 35
2025
Q3 		$117K Buy
+10,000
New +$99.5K 0.11% 39
2025
Q2 		– Sell
-153,500
Closed -$1.03M – 52
2025
Q1 		$1.03M Buy
+153,500
New +$1.47M 1.06% 21

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Velan Capital Investment Management's IMNM Position: Q1 2026 in Review

Velan Capital Investment Management held its Immunome (IMNM) position steady in Q1 2026 at 10,000 shares worth $219K. The position accounts for 0.14% of the portfolio, ranked #37.

Velan Capital Investment Management first reported a position in IMNM in Q1 2025 and has held it in 4 quarters since. The position peaked at $1.03M in Q1 2025. 201 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Velan Capital Investment Management held 10,000 shares of Immunome worth $219K as of Q1 2026.
  • Velan Capital Investment Management left its Immunome share count unchanged in Q1 2026.
  • Immunome made up 0.14% of Velan Capital Investment Management's portfolio in Q1 2026, its #37 holding.
  • Velan Capital Investment Management first reported a position in Immunome in Q1 2025 and has held it in 4 quarters since.
  • Velan Capital Investment Management's Immunome position peaked at $1.03M in Q1 2025.
  • 201 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Velan Capital Investment Management's 13F filing for Q1 2026, filed 15 May 2026.